Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Details:
The prospective, multicenter, randomized, controlled clinical study will investigate the efficacy of PalinGen® Flow treatment in adults with chronic ulcers of the lower extremities due to venous stasis or diabetic etiologies.
Lead Product(s): PalinGen Flow
Therapeutic Area: Cardiology/Vascular Diseases Product Name: PalinGen Flow
Highest Development Status: Phase IIProduct Type: Cell and Gene therapy
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable October 20, 2020